Literature DB >> 24696291

MicroRNA-25 expression level is an independent prognostic factor in epithelial ovarian cancer.

X Wang1, X Meng, H Li, W Liu, S Shen, Z Gao.   

Abstract

OBJECTIVES: The present study aimed to investigate the expression level of MicroRNA-25 (miR-25) in epithelial ovarian cancer (EOC) tissue, and examine its relationship with clinicopathological factors and prognosis of patients with EOC.
METHODS: Expression levels of miR-25 in 86 pairs of EOC tissue and adjacent normal tissue were measured by quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR). The comparison of the expression level of miR-25 between EOC tissue and adjacent normal tissue was performed using the two-sample Student's t test. The correlation between the expression of miR-25 and clinicopathological characters was assessed with the two-sample Student's t test. The overall survival was analyzed by log-rank test, and survival curves were plotted according to Kaplan-Meier.
RESULTS: The expression level of miR-25 in EOC tissue was significantly higher than in adjacent normal tissue. The miR-25 expression level was significantly positively correlated with tumor stage, histology, and regional lymph node involvement (P < 0.05). Kaplan-Meier analysis showed that patients with higher levels of miR-25 had significantly poorer survival than those with lower expression of this miRNA in patients, with a 6-year overall survival of 15.96 and 45.89 %, respectively, (P = 0.001). In the multivariate Cox proportional hazards analysis, high miR-25 expression was independently associated with poor survival (P = 0.002; HR = 2.119; 95 % CI = 1.568-3.221).
CONCLUSION: The increased expression of miR-25 is closely related to poor prognosis of EOC, indicating that miR-25 may serve as a predictive biomarker for the prognosis of EOC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24696291     DOI: 10.1007/s12094-014-1178-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  19 in total

1.  MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.

Authors:  Haiyan Zhang; Zhi Zuo; Xin Lu; Li Wang; Haiyan Wang; Zhiling Zhu
Journal:  Oncol Rep       Date:  2011-11-08       Impact factor: 3.906

2.  Ovarian cancer screening and peritoneal carcinomatosis: standards, 'omics' and miRNAs for personalized management.

Authors:  John Spiliotis; Eugenia Halkia; Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2011-06       Impact factor: 5.225

Review 3.  Molecular genetics and epidemiology of epithelial ovarian cancer (Review).

Authors:  Shoji Haruta; Naoto Furukawa; Yoriko Yoshizawa; Taihei Tsunemi; Akira Nagai; Ryuji Kawaguchi; Yasuhito Tanase; Shozo Yoshida; Hiroshi Kobayashi
Journal:  Oncol Rep       Date:  2011-09-12       Impact factor: 3.906

Review 4.  Clinical applications for microRNAs in cancer.

Authors:  S P Nana-Sinkam; C M Croce
Journal:  Clin Pharmacol Ther       Date:  2012-12-05       Impact factor: 6.875

5.  MicroRNA-106b-25 cluster targets β-TRCP2, increases the expression of Snail and enhances cell migration and invasion in H1299 (non small cell lung cancer) cells.

Authors:  Udainiya Savita; Devarajan Karunagaran
Journal:  Biochem Biophys Res Commun       Date:  2013-04-20       Impact factor: 3.575

6.  Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.

Authors:  Laura Poliseno; Leonardo Salmena; Luisa Riccardi; Alessandro Fornari; Min Sup Song; Robin M Hobbs; Paolo Sportoletti; Shorheh Varmeh; Ainara Egia; Giuseppe Fedele; Lucia Rameh; Massimo Loda; Pier Paolo Pandolfi
Journal:  Sci Signal       Date:  2010-04-13       Impact factor: 8.192

7.  Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma.

Authors:  Baek-Hui Kim; Soon Won Hong; Aeree Kim; Seung Ho Choi; Sun Och Yoon
Journal:  J Surg Oncol       Date:  2012-09-20       Impact factor: 3.454

8.  Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.

Authors:  Yang Li; Weiqi Tan; Thomas W L Neo; Myat O Aung; Shanthi Wasser; Seng G Lim; Theresa M C Tan
Journal:  Cancer Sci       Date:  2009-04-15       Impact factor: 6.716

Review 9.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

10.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.

Authors:  Young-Kook Kim; Jieun Yu; Tae Su Han; Seong-Yeon Park; Bumjin Namkoong; Dong Hyuk Kim; Keun Hur; Moon-Won Yoo; Hyuk-Joon Lee; Han-Kwang Yang; V Narry Kim
Journal:  Nucleic Acids Res       Date:  2009-01-19       Impact factor: 16.971

View more
  20 in total

1.  Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis.

Authors:  Haiyan Min; Shanshan Fan; Shiyu Song; Yi Zhuang; Hui Li; Yongzheng Wu; Hourong Cai; Long Yi; Jinghong Dai; Qian Gao
Journal:  Diagn Pathol       Date:  2016-11-23       Impact factor: 2.644

2.  MicroRNA-183 correlates cancer prognosis, regulates cancer proliferation and bufalin sensitivity in epithelial ovarian caner.

Authors:  Huixiao Chen; Ling Zhang; Lili Zhang; Jing Du; Hongying Wang; Bin Wang
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

Review 3.  Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.

Authors:  Marta Szajnik; Małgorzata Czystowska-Kuźmicz; Esther Elishaev; Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2016-06-23       Impact factor: 5.225

4.  Prognostic role of microRNA-25 in cancers: evidence from a meta-analysis.

Authors:  Jingjing Qu; Min Li; Wen Zhong; Chengping Hu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.

Authors:  Yunyan Gu; Mengmeng Zhang; Fuduan Peng; Lei Fang; Yuanyuan Zhang; Haihai Liang; Wenbin Zhou; Lu Ao; Zheng Guo
Journal:  Oncotarget       Date:  2015-02-10

6.  Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.

Authors:  Min Li; Qingbin Song; Qinbin Song; Hang Li; Yi Lou; Lili Wang
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

Review 7.  The role of microRNAs in ovarian cancer.

Authors:  Yasuto Kinose; Kenjiro Sawada; Koji Nakamura; Tadashi Kimura
Journal:  Biomed Res Int       Date:  2014-09-10       Impact factor: 3.411

Review 8.  Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.

Authors:  Yan Sun; Fei Guo; Marina Bagnoli; Feng-Xia Xue; Bao-Cun Sun; Ilya Shmulevich; Delia Mezzanzanica; Ke-Xin Chen; Anil K Sood; Da Yang; Wei Zhang
Journal:  Chin J Cancer       Date:  2015-01

9.  Evaluation of circulating microRNAs-211 and 25 as diagnostic biomarkers of colorectal cancer.

Authors:  Eman Radwan; Asmaa S Shaltout; Shima Gafar Mansor; Engy A Shafik; Wael A Abbas; Mahmoud Refaat Shehata; Maha Ali
Journal:  Mol Biol Rep       Date:  2021-06-16       Impact factor: 2.316

10.  MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.

Authors:  Shujun Feng; Wenjing Pan; Ye Jin; Jianhua Zheng
Journal:  Tumour Biol       Date:  2014-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.